Crossref
Aligning Alzheimer Trials With Disease Demographics—From Rhetoric to Reality
JAMA Network Open · 27.03.2026 · 9 (3) · e262373
DOI: 10.1001/jamanetworkopen.2026.2373 ↗Kurz gefasst
Fachartikel in der Zeitschrift JAMA Network Open, online erschienen am 27.03.2026. Verfasst von Omonigho M Bubu. Beteiligte Einrichtung: Department of Psychiatry, NYU Grossman School of Medicine, New York, New York. Die Arbeit nennt 8 Literaturangaben. Gefördert von: NIA NIH HHS.
Themen: Demenz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Psychiatry, NYU Grossman School of Medicine, New York, New York.
- Department of Population Health, NYU Grossman School of Medicine, New York, New York.
- Department of Neurology, NYU Grossman School of Medicine, New York, New York.
- NYU Alzheimer's Disease Research Center, NYU Grossman School of Medicine, New York, New York.
- Institute Excellence in Health Equity, NYU Grossman School of Medicine, New York, New York.
- Institute of Translational Neuroscience, NYU Grossman School of Medicine, New York, New York.
Förderung
- NIA NIH HHS
Zitieren
APA
Bubu, O. M. (2026). Aligning Alzheimer Trials With Disease Demographics—From Rhetoric to Reality. JAMA Network Open, 9(3), e262373. https://doi.org/10.1001/jamanetworkopen.2026.2373
Vancouver
Bubu OM. Aligning Alzheimer Trials With Disease Demographics—From Rhetoric to Reality. JAMA Network Open. 2026;9(3):e262373. doi:10.1001/jamanetworkopen.2026.2373
BibTeX
@article{Bubu2026,
author = {Bubu, Omonigho M},
title = {Aligning Alzheimer Trials With Disease Demographics—From Rhetoric to Reality},
journal = {JAMA Network Open},
year = {2026},
volume = {9},
number = {3},
pages = {e262373},
doi = {10.1001/jamanetworkopen.2026.2373}
}
EUVIMED